Enveric Biosciences (ENVB) FCF Margin (2014 - 2025)
Enveric Biosciences (ENVB) reported FCF Margin of -4.71% for Q3 2020, down 0.50 percentage points from the prior quarter.
Enveric Biosciences (ENVB) FCF Margin (2014 - 2025) Analysis & Trends
Over the twelve months ended Sep 30, 2020, Enveric Biosciences' FCF Margin came in at -2.59%, up 3.46 percentage points year-over-year; for FY2019, it came in at -1.83%, up 4.12 percentage points from FY2018.
- FCF Margin has a four-year change of +17.43 percentage points (FY2015 to FY2019).
- By year, FCF Margin came in at -5.95% in FY2018 (-0.30 pp), -5.65% in FY2017 (+1.91 pp), -7.56% in FY2016 (+11.70 pp) and -19.26% in FY2015.
- Five-year quarterly FCF Margin spans a low of -24.20% in Q4 2016 and a high of 8.49% in Q4 2019.
- Year over year, FCF Margin gained in two of the last six quarters, with an average year-over-year change of +0.89 percentage points.
- The high point for year-over-year FCF Margin in five years was Q3 2016 (a gain of 78.36 percentage points); the low point was Q4 2016 (a drop of 29.72 percentage points).
- Per Business Quant data, the three quarters before Q3 2020 came in at -4.21% (Q2 2020), -9.76% (Q1 2020) and 8.49% (Q4 2019).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 33.76% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 28.82% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 18.33% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 26.96% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 6.55% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.70% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 44.00% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.01% |
| 10 | Enveric Biosciences | 6.02 Mn | -15.62 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -757,283.21% |
| Mar 31, 2025 | -73,541.88% |
| Jun 30, 2024 | -5,559.84% |
| Mar 31, 2024 | -5,624.61% |
| Dec 31, 2023 | -309,369.79% |
| Sep 30, 2023 | -122,505.19% |
| Jun 30, 2023 | -487,547.93% |
| Sep 30, 2020 | -4.71% |
| Jun 30, 2020 | -4.21% |
| Mar 31, 2020 | -9.76% |
| Dec 31, 2019 | 8.49% |
| Jun 30, 2019 | -4.59% |
| Mar 31, 2019 | -9.32% |
| Dec 31, 2018 | -9.58% |
| Sep 30, 2018 | -12.11% |
| Jun 30, 2018 | 1.50% |
| Mar 31, 2018 | -4.15% |
| Dec 31, 2017 | -8.19% |
| Sep 30, 2017 | -0.79% |
| Jun 30, 2017 | -7.01% |
Enveric Biosciences FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=ENVB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "ENVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=ENVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();